Chefaa announced that it has received $5.25 million in funding from Newtown Partners Ltd, Global Brain Co., Ltd., GMS Capital Partners LLC, Verod-Kepple Africa Ventures, M3, Inc.
December 18, 2023
Share
Chefaa announced that it has raised $5.25 million in a round of funding co-led by returning investors Newtown Partners (Pty) Ltd and GB-VII Growth Fund Investment Limited Partnership,a fund managed by Global Brain Co., Ltd. on December 19, 2023. The transaction also included participation from returning investor GMS Capital Partners LLC,new investors Verod-Kepple Africa Ventures and M3, Inc.
M3, Inc. specializes in the provision of online services dedicated to the health field. Net sales (before intra-group eliminations) break down by activity as follows:
- medical marketing support services (40.3%): services enabling doctors and health professionals to search for medical resources, use the latest medical news, exchange opinions, learn about medical products and services and career development, etc. via m3.com., MR-kun, MDLinx and MEDI: GATE;
- support services to medical institutions (16.5%):
- clinical trial related services (10.7%): clinical trial support and clinical trial operations management services;
- human resources services (6.6%);
- other (1.6%): including marketing assistance and surveys of affiliated medical companies via specialized sites.
The balance of sales (24.3%) concerns international activities.
Chefaa announced that it has received $5.25 million in funding from Newtown Partners Ltd, Global Brain Co., Ltd., GMS Capital Partners LLC, Verod-Kepple Africa Ventures, M3, Inc.
M3, INC. 
